glucagon in retatrutide mechanism triple agonist glp-1 gip receptor Retatrutide's Mislabeling: GLP-1, GIP, and Glucagon Receptors Substack Series 3 of 6:

Despite broad preclinical support, human data are extremely limited

And thats why GLP-1s are very confusing, but if you want a patient to be successful on them, you want to make sure youve got the lifestyle, you got the right expectations, you know what the entry point is, what the duration is, and more importantly, what happens when they hit a weight and quote unquote, what is the endpoint of GLP-1s

Recommended Next Reads Build a stronger tracking plan with our best GLP-1 app guide, GLP-1 tracker app overview, semaglutide guide, and tirzepatide guide

Patients may review the currently listed compounded GLP-1 options on the official MEDVi website and complete an online health evaluation to determine potential eligibility